Terry Feest

6.3k total citations · 1 hit paper
75 papers, 3.6k citations indexed

About

Terry Feest is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Terry Feest has authored 75 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Nephrology, 22 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Terry Feest's work include Dialysis and Renal Disease Management (27 papers), Chronic Kidney Disease and Diabetes (11 papers) and Renal and Vascular Pathologies (11 papers). Terry Feest is often cited by papers focused on Dialysis and Renal Disease Management (27 papers), Chronic Kidney Disease and Diabetes (11 papers) and Renal and Vascular Pathologies (11 papers). Terry Feest collaborates with scholars based in United Kingdom, Netherlands and Germany. Terry Feest's co-authors include David Kerr, M K Ward, Oliver Wrong, I S Parkinson, Anthony G.W. Norden, Samar Hamad, Alfred D. Round, H. A. Ellis, Anne K. Soutar and David M. Vigushin and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Terry Feest

71 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human lysozyme gene mutations cause hereditary systemic amyloidosis

1993 550 citations Terry Feest et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Terry Feest United Kingdom	29	1.2k	984	543	458	452	75	3.6k
Sharon Andreoli United States	32	1.4k 1.2×	568 0.6×	338 0.6×	211 0.5×	247 0.5×	123	3.7k
Abdulla K. Salahudeen United States	33	1.3k 1.1×	511 0.5×	194 0.4×	103 0.2×	510 1.1×	67	3.8k
Martha J. Shrubsole United States	38	284 0.2×	1.2k 1.3×	809 1.5×	153 0.3×	404 0.9×	178	4.4k
Mohammadreza Ardalan Iran	33	712 0.6×	850 0.9×	150 0.3×	146 0.3×	225 0.5×	281	3.9k
Diego Brancaccio Italy	34	1.5k 1.2×	1.1k 1.1×	626 1.2×	48 0.1×	303 0.7×	214	4.0k
Mark E. Rosenberg United States	25	696 0.6×	1.6k 1.6×	265 0.5×	52 0.1×	259 0.6×	73	3.8k
Vincent W. Dennis United States	30	1.1k 0.9×	798 0.8×	191 0.4×	78 0.2×	213 0.5×	69	3.3k
A. Meguid El Nahas United Kingdom	39	2.3k 1.9×	924 0.9×	177 0.3×	70 0.2×	365 0.8×	108	5.0k
Peter Marckmann Denmark	41	638 0.5×	256 0.3×	1.2k 2.2×	121 0.3×	791 1.8×	108	5.1k
Ja‐Liang Lin Taiwan	30	501 0.4×	542 0.6×	357 0.7×	425 0.9×	53 0.1×	104	2.6k

Countries citing papers authored by Terry Feest

Since Specialization

Citations

This map shows the geographic impact of Terry Feest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry Feest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry Feest more than expected).

Fields of papers citing papers by Terry Feest

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry Feest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry Feest. The network helps show where Terry Feest may publish in the future.

Co-authorship network of co-authors of Terry Feest

This figure shows the co-authorship network connecting the top 25 collaborators of Terry Feest. A scholar is included among the top collaborators of Terry Feest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry Feest. Terry Feest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Steenkamp, Retha, Clare Castledine, & Terry Feest. (2012). Chapter 6 Survival and Causes of Death of UK Adult Patients on Renal Replacement Therapy in 2010: National and Centre-Speciﬁc Analyses. Nephron Clinical Practice. 120(s1). c105–c135. 22 indexed citations

Ravanan, Rommel, et al.. (2011). Chapter 13: Centre Variation in Access to Renal Transplantation in the UK (2004–2006). Nephron Clinical Practice. 119(s2). c239–c248. 4 indexed citations

Gilg, Julie, et al.. (2011). Chapter 4: Comorbidities and Current Smoking Status amongst Patients Starting Renal Replacement Therapy in England, Wales and Northern Ireland from 2008 to 2009. Nephron Clinical Practice. 119(s2). c85–c96. 19 indexed citations

Casula, Anna, et al.. (2011). Chapter 8: Adequacy of Haemodialysis in UK Adult Patients in 2009: National and Centre-Specific Analyses. Nephron Clinical Practice. 119(s2). c141–c147. 3 indexed citations

Caskey, Fergus, Paul Roderick, Günter Edenharter, et al.. (2006). Exploring the Differences in Epidemiology of Treated ESRD Between Germany and England and Wales. American Journal of Kidney Diseases. 47(3). 445–454. 43 indexed citations

Manen, Jeannette G. van, Paul C. W. van Dijk, Vianda S Stel, et al.. (2006). Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrology Dialysis Transplantation. 22(1). 187–195. 71 indexed citations

Roderick, Paul, T. Nicholson, R. J. Mehta, et al.. (2005). An evaluation of the costs, effectiveness and quality of renal replacement therapy provision in renal satellite units in England and Wales. Health Technology Assessment. 9(24). 1–178. 99 indexed citations

Feest, Terry, et al.. (2004). Trends in adult renal replacement therapy in the UK: 1982-2002. QJM. 98(1). 21–28. 44 indexed citations

Wolf, Matthias T. F., Stephanie M. Karle, Manfred Anlauf, et al.. (2003). Refinement of the critical region for MCKD1 by detection of transcontinental haplotype sharing. Kidney International. 64(3). 788–792. 13 indexed citations

10.

Fuchshuber, Arno, Sabine Kroiss, Stephanie M. Karle, et al.. (2001). Refinement of the Gene Locus for Autosomal Dominant Medullary Cystic Kidney Disease Type 1 (MCKD1) and Construction of a Physical and Partial Transcriptional Map of the Region. Genomics. 72(3). 278–284. 19 indexed citations

11.

Feest, Terry. (1999). Can intensive treatment alter the progress of established diabetic nephropathy to end-stage renal failure?. QJM. 92(5). 275–282. 20 indexed citations

12.

Sculpher, Mark, Brian Ferguson, Joan E. Humphreys, et al.. (1991). Screening for Treatable Diabetic Retinopathy: a Comparison of Different Methods. Diabetic Medicine. 8(4). 371–377. 109 indexed citations

13.

Feest, Terry, Chandra D. Mistry, D S Grimes, & N P Mallick. (1990). Incidence of advanced chronic renal failure and the need for end stage renal replacement treatment.. BMJ. 301(6757). 897–900. 106 indexed citations

14.

Feest, Terry, et al.. (1990). Protocol for increasing organ donation after cerebrovascular deaths in a district general hospital. The Lancet. 335(8698). 1133–1135. 84 indexed citations

15.

Holman, R R, et al.. (1983). VIBRATION SENSORY THRESHOLD - A SIMPLE GUIDE TO ADEQUACY OF DIALYSIS. Kidney International. 23. 560–560. 1 indexed citations

16.

Feest, Terry, S.J. Proctor, Robert S. Brown, & O M Wrong. (1978). Nephrocalcinosis: another cause of renal erythrocytosis.. BMJ. 2(6137). 605.1–605. 6 indexed citations

17.

Fairclough, P D, Terry Feest, V. S. Chadwick, & M. L. Clark. (1977). Effect of sodium chenodeoxycholate on oxalate absorption from the excluded human colon--a mechanism for 'enteric' hyperoxaluria.. Gut. 18(3). 240–244. 26 indexed citations

18.

Ellis, H. A., Alkis Pierides, Terry Feest, M K Ward, & David Kerr. (1977). HISTOPATHOLOGY OF RENAL OSTEODYSTROPHY WITH PARTICULAR REFERENCE TO THE EFFECTS OF lα‐HYDROXYVITAMIN D₃ IN PATIENTS TREATED BY LONG‐TERM HAEMODIALYSIS. Clinical Endocrinology. 7(s1). 31s–38s. 43 indexed citations

19.

Feest, Terry, et al.. (1976). Successful treatment of myeloma kidney by diuresis and plasmaphoresis.. BMJ. 1(6008). 503–504. 35 indexed citations

20.

Feest, Terry. (1976). Low molecular weight dextran: a continuing cause of acute renal failure.. BMJ. 2(6047). 1300–1300. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact